Endo Eurofin Unlimited Company Sustainability Profile
Endo Eurofin Unlimited Company, commonly referred to as Endo Eurofin, is a prominent player in the pharmaceutical and biotechnology industry, headquartered in Ireland (IE). Founded in the early 2000s, the company has established itself as a leader in providing innovative solutions in drug development and testing services, catering to a diverse range of clients across Europe and beyond. With a strong focus on quality and compliance, Endo Eurofin offers a unique portfolio of services, including analytical testing, bioanalytical services, and regulatory support. Their commitment to excellence has earned them a solid market position, recognised for their advanced methodologies and customer-centric approach. As they continue to expand their operational footprint, Endo Eurofin remains dedicated to driving advancements in healthcare and ensuring the safety and efficacy of pharmaceutical products.
DitchCarbon Score
How does Endo Eurofin Unlimited Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Endo Eurofin Unlimited Company's score of 11 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Endo Eurofin Unlimited Company, headquartered in Ireland (IE), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Endo Inc., which may influence its climate commitments and reporting practices. As of now, Endo Eurofin Unlimited Company has not established any documented reduction targets or climate pledges. This lack of specific initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the absence of direct emissions data, it is important to note that the company’s climate commitments and performance may be informed by the broader corporate family’s initiatives. However, no specific targets or initiatives from Endo Inc. have been detailed in the provided information. In summary, Endo Eurofin Unlimited Company is currently without reported carbon emissions or defined climate commitments, reflecting a potential area for future development in sustainability practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 27,475,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 37,395,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - |
How Carbon Intensive is Endo Eurofin Unlimited Company's Industry?
How Carbon Intensive is Endo Eurofin Unlimited Company's Location?
Endo Eurofin Unlimited Company's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Endo Eurofin Unlimited Company has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.